A new study found people lost an average of 32.4 pounds while on semaglutide and tirzepatide. People who discontinue GLP-1 drugs regained nearly 22 pounds within a year. They returned to their ...
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Vinaya Gogineni, Vanderbilt University and Anna Barton Bradley, Vanderbilt University ...